Equity in Access Research Grants
Funds research to identify and address barriers to equitable blood cancer care, generating evidence to inform policy and practice for improved access among disadvantaged and underrepresented groups.
Funder: Leukemia & Lymphoma Society
Due Dates: September 10, 2026 (Letter of Intent) | February 4, 2027 (Full proposal for invited applicants)
Funding Amounts: Recent awards have totaled nearly $5M for five-year projects; typical award size and duration may vary by proposal scope.
Summary: Funds innovative research to identify and address barriers to equitable care for blood cancer patients, guiding policy and practice changes to improve access for disadvantaged groups.
Description
This program supports research projects that advance equitable access to care for blood cancer patients and survivors. The focus is on generating actionable evidence to guide policy reform and healthcare practice changes, particularly addressing the impact of social, economic, and environmental disadvantages. Funded studies have investigated how insurance status, policy changes, and healthcare infrastructure influence access to cancer care, and have tested interventions to expand clinical trial participation among underrepresented groups, such as Veterans and minoritized populations. The ultimate aim is to inform best practices and policy to advance health equity in blood cancer care.
